biotech
biotech Articles
Dermira shares made a solid gain to close out the week after the firm announced a key approval from the FDA for Qbrexza (glycopyrronium) cloth.
Published:
Last Updated:
Gemphire Therapeutics shares more than doubled early on Thursday after the company announced results from a midstage trial for severe hypertriglyceridemia.
Published:
Last Updated:
Arsanis shares were absolutely crushed on Thursday after the company provided an update from its midstage trial. The company decided that it will cut and run, ultimately discontinuing its pneumonia...
Published:
Last Updated:
Akebia Therapeutics and Keryx Biopharmaceuticals each saw their shares take a dive on Thursday following news that these two companies had agreed upon a merger.
Published:
Last Updated:
Pain Therapeutics shares were destroyed on Wednesday after a vote from the FDA was announced.
Published:
Last Updated:
Janney Montgomery Scott has initiated coverage of Selecta Biosciences with a price target that represents huge upside.
Published:
Last Updated:
Cara Therapeutics shares made a solid gain on Wednesday after the biotech announced positive results from a midstage trial.
Published:
Last Updated:
Summit Therapeutics is another biopharma company that is paying the price on Wednesday.
Published:
Last Updated:
Aquinox Pharmaceuticals saw its shares crash on Wednesday after the firm gave a disappointing update for a late-stage trial.
Published:
Last Updated:
The June 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Published:
Last Updated:
Puma Biotechnology shares were climbing on Tuesday after the company announced that it expects a positive outcome in Europe.
Published:
Last Updated:
Achaogen shares were crumbling on Tuesday following some mixed news from the FDA regarding its treatment of urinary tract and bloodstream infections.
Published:
Last Updated:
Achieve Life Sciences saw its shares skyrocket on Tuesday after the company announced positive results from its smoking cessation study.
Published:
Last Updated:
Infinity Pharmaceuticals shares made a healthy gain early on Tuesday after the firm announced a clinical collaboration with Arcus Biosciences.
Published:
Last Updated:
A pioneer in the development of a new class of medicines, Rubius Therapeutics has filed with the SEC regarding its initial public offering.
Published:
Last Updated: